Not Signed In -
Irritable Bowel Syndrome |
Irritable Bowel Syndrome (IBS); Spastic Colon |
Clinical Trial: Characterization of Pain Processing Mechanisms in Irritable Bowel Syndrome
This study has been completed.
|
Purpose
The purpose of this study is to provide new information and to determine which kinds of brief, tolerable, experimental pain are affected by the drugs being studied in patients with irritable bowel syndrome, a disease that causes chronic abdominal pain. The effects of dextromethorphan, naloxone, and fentanyl on experimental pain stimuli will be tested in these studies to better understand what causes irritable bowel syndrome.
| Condition | Treatment or Intervention |
|---|---|
| Irritable Bowel Syndrome | Procedure: Viceral Perception Testing |
MedlinePlus related topics: Irritable Bowel Syndrome
Study Type: Interventional
Study Design: Diagnostic, Non-Randomized, Double-Blind, Active Control, Single Group Assignment
Official Title: Central Nervous System Modulation of Visceral Pain in Persian Gulf War Syndrome
Study start: September 2000
Eligibility
Ages Eligible for Study: 18 Years - 72 Years, Genders Eligible for Study: Both
Accepts Healthy Volunteers
Criteria
- Patients with irritable bowel syndrome and healthy pain-free individuals (as controls) will be studied.
- No medical condition that would contraindicate use of dextromethorphan, fentanyl or naloxone.
Location Information
Florida
Malcolm Randall VA Medical Center, Gainesville, Florida, 32608, United States
More Information
Record last reviewed: December 2004
Last Updated: January 3, 2005
Record first received: December 30, 2004
ClinicalTrials.gov Identifier: NCT00100425
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 8, 2005
email this page
print this page
bookmark this page
feedback on this page
